INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 125 filers reported holding INTERSECT ENT INC in Q3 2021. The put-call ratio across all filers is 3.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $673,000 | +2.7% | 24,010 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $655,000 | +0.2% | 23,975 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $654,000 | +29.0% | 24,052 | -18.9% | 0.00% | 0.0% |
| Q2 2021 | $507,000 | -17.4% | 29,661 | +0.9% | 0.00% | 0.0% |
| Q1 2021 | $614,000 | -8.8% | 29,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $673,000 | +26.5% | 29,400 | -9.8% | 0.00% | 0.0% |
| Q3 2020 | $532,000 | +42.2% | 32,600 | +18.1% | 0.00% | – |
| Q2 2020 | $374,000 | +14.4% | 27,600 | 0.0% | 0.00% | – |
| Q1 2020 | $327,000 | -52.4% | 27,600 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $687,000 | +19.5% | 27,600 | -18.3% | 0.00% | 0.0% |
| Q3 2019 | $575,000 | -25.2% | 33,800 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $769,000 | -18.6% | 33,800 | +15.0% | 0.00% | 0.0% |
| Q1 2019 | $945,000 | +14.1% | 29,400 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $828,000 | -12.8% | 29,400 | -10.9% | 0.00% | 0.0% |
| Q3 2018 | $949,000 | -45.6% | 33,000 | -29.1% | 0.00% | -50.0% |
| Q2 2018 | $1,744,000 | -16.1% | 46,567 | -12.0% | 0.00% | -33.3% |
| Q1 2018 | $2,079,000 | +103.4% | 52,900 | +67.7% | 0.00% | +200.0% |
| Q4 2017 | $1,022,000 | +14.7% | 31,551 | +10.3% | 0.00% | 0.0% |
| Q3 2017 | $891,000 | +11.5% | 28,600 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $799,000 | +63.1% | 28,600 | -0.0% | 0.00% | 0.0% |
| Q1 2017 | $490,000 | +41.6% | 28,601 | +0.0% | 0.00% | – |
| Q4 2016 | $346,000 | -23.6% | 28,600 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $453,000 | +117.8% | 28,600 | +77.6% | 0.00% | – |
| Q2 2016 | $208,000 | -77.3% | 16,100 | -66.6% | 0.00% | -100.0% |
| Q1 2016 | $916,000 | -15.5% | 48,188 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $1,084,000 | +187.5% | 48,188 | +199.3% | 0.00% | +100.0% |
| Q3 2015 | $377,000 | -31.5% | 16,100 | -16.2% | 0.00% | 0.0% |
| Q2 2015 | $550,000 | +179.2% | 19,216 | +151.8% | 0.00% | – |
| Q1 2015 | $197,000 | – | 7,632 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |